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Excessive intake of fat is a major risk factor for lifestyle-related diseases such as heart
disease and also affects brain function such as object recognition memory, social
recognition, anxiety behavior, and depression-like behavior. Although oxytocin (OXT)
has been reported to improve object recognition, social recognition, anxiety behavior,
and depression-like behavior in specific conditions, previous studies did not explore the
impact of OXT in high-fat diet (HFD)-fed mice. Furthermore, it remains unclear whether
intake of HFD affects OXT/oxytocin receptor (OXTR) in the brain. Here, we demonstrated
that peripheral OXT administration improves not only social recognition but also object
recognition and depressive-like behavior in HFD-fed mice. In contrast, peripheral OXT
administration to HFD-fed male mice increased fear and anxiety-related behavior. In
addition, we observed that intake of HFD decreased OXTR and c-fos mRNA expression
in the hippocampus, specifically. Furthermore, peripheral OXT administration increased
OXT mRNA expression in the hypothalamus. Altogether, these findings suggest that
OXT has the potential to improve various recognition memory processes via peripheral
administration but also has side effects that increase fear-related behavior in males.
Keywords: oxytocin, high-fat diet, social recognition, object recognition memory, anxiety behavior, fear-related
behavior, depression behavior
INTRODUCTION
Excessive fat intake is a major risk factor for lifestyle-related diseases such as obesity, diabetes, and
metabolic syndrome. Obesity has been reported to be a risk factor for Alzheimer’s disease (1, 2)
and cognitive decline (3) in humans. A correlation has also been found between depression-like
behavior (4), anxiety behavior (5), and obesity. In animals, previous studies have shown that intake
of a high-fat diet (HFD) decreases social recognition and object recognition memory, and increases
anxiety related behavior as well as depression-like behavior (6–9). Oxytocin (OXT) is a 9-amino
acid neuropeptide hormone synthesized in the paraventricular nucleus (PVN) and supraoptic
nucleus (SON) (10) and is secreted into blood by axons projecting axons to the posterior pituitary
gland (11). Synthesized OXT has various physiological functions in a wide range of peripheral
tissues, including the mammary gland, uterine smooth muscle, tongue, and bone tissue. All these
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tissues express oxytocin receptor (OXTR), a G protein-coupled
receptor (12, 13) coupled to the q/11 type Gα subunit. The
peripheral OXT/OXTR system has physiological actions such
as milk ejection, parturition, and control of bone formation.
OXTR expression occurs in various brain regions, including the
PVN, lateral septal (LS) nucleus, hippocampus, medial amygdala
(MeA), medial preoptic area (MPOA), and the bed nucleus of
the stria terminalis (BNST). OXTR-expressing neurons of the
PVN are exclusively glutamatergic. Moreover, OXTR expressing
neurons of the BNST are GABAergic (14). OXT reaches each
nucleus through the axons of oxytocinergic neurons. Moreover,
it is hypothesized that OXT is released directly in these brain
regions non-synaptically (15). A range of behaviors including
social behaviors, and especially prosocial behaviors, are suspected
to be controlled through signal regulation via the OXT/OXTR
system. More specifically, pair bonding, maternal behavior,
empathetic behavior, social recognition, and offensive behavior
are thought to be controlled by the OXT/OXTR system (13, 16–
19). OXTRs in the hippocampus regulate social recognition (20–
22) and OXTRs in the amygdala controls social recognition and
fear expression (23, 24). OXT or OXTR gene-deficient mice,
which exhibit behavioral phenotypes such as decreased social
cognitive function (25), are established as an animal model of
autistic spectrum disorders (ASD). Furthermore, the OXTR is
a pharmacological drug target, and human studies have shown
that intranasal administration of OXT, a natural OXTR agonist,
to ASD patients improved their social communication and social
reciprocity (26, 27). Amelioration in social cognitive function
was also observed in a valproic acid (VPA)-treated ASD mouse
model, upon administration of intranasal OXT (28).
The effects caused by peripheral administration of OXT
on social recognition and object recognition are unclear.
In previous studies, the effect of peripherally administrated
OXT on cognitive function varied among animal models. For
example, intranasal administration of OXT to VPA-treated mice
restored social cognitive function but did not improve objective
cognitive function (28). In addition, it has been reported that
intracerebroventricular (i.c.v.) administration of OXT to Shank3-
knockout (KO) mice can restore their social cognitive function
(29), and nasal administration of OXT to tail shock stress-treated
rats can also restore their cognitive function (30). Peripheral
administration of OXT has antidepressant effects (31), and has
also been shown to exert the opposite effects on anxiety behavior.
OXT may act on the PVN, and OXT administration to PVN and
ventricle exhibit anxiolytic effects (32, 33). However, anxiogenic
effects have been caused by repeated OXT i.c.v. administration
(34) and thismay be related to the septal OXTRs (35). In addition,
because OXT KO mice and OXTR KO mice show significantly
increased body weight (16, 36), the OXT/OXTR system appears
to be strongly involved in obesity and/or control of food intake
(37, 38). As OXT appears to have a dual function in body weight
control and recognition, we speculated that OXT ismore effective
for ameliorating the recognition impairment caused by a HFD.
However, the effects of peripherally administrated OXT on
social cognition, object recognition, anxiety, and depression-
like behavior in mice on a HFD have not been reported
to date. The aim of this study was thus to evaluate the
effects of peripherally administrated OXT on the various
cognitive functions—social recognition, object recognition,
anxiety behavior, and depression-like behavior—in HFD-fed
mice. In addition, by inferring the relationship between HFD
intake and the OXT/OXTR system in the brain, we attempted
to elucidate the mechanisms underlying the cognitive function
deficits that we observed in HFD-fed mice.
MATERIALS AND METHODS
Animals and Diets
C57BL/6J male mice were obtained from Japan SLC
(Hamamatsu, Japan). Forty-nine mice per group were housed
in individual cages with a 12-h light-dark cycle. The mice were
randomly divided into three groups (ND: normal diet; HFD:
high-fat diet; and HFD + OXT: high-fat diet + oxytocin). The
ND group was fed normal diet (D12450J; Research diet, New
Brunswick, NJ). Both the HFD and HFD + OXT groups were
fed HFD (D12492; Research diet, New Brunswick, NJ). The
mice were fed the test diet starting at the age of 6 weeks for a
duration of 10 weeks before the behavioral tests were initiated.
All groups had ad libitum access to food and water. Altogether,
we performed four independent experiments involving all three
groups of mice (Experiment A–D; Figure 1). The body weight of
the mice was measured once every 2 weeks until the behavioral
testing (Figure 2). All animal experiments were approved by
the Institutional Animal Care and Use Committee of Tohoku
University and the Animal Experiment Committee of Nippon
Flour Mills.
Drug Administration
OXT was purchased from Peptide Institute Inc. (Osaka, Japan)
and dissolved in 0.9% NaCl solution before use. OXT (1 mg/kg)
or saline was intraperitoneally administrated at a volume of 10
ml/kg body weight, 45min before each behavioral test (Figure 1).
We administrated saline to the ND and HFD group, and OXT to
the HFD + OXT group. We used the same dose (1 mg/kg) of
OXT as in previous studies (7, 39, 40).
Behavioral Tests
The battery of behavioral tests began after intakes of the test diet
for 10 weeks (Figure 1). Thirty-ninemice per groupwere used for
the behavioral testing. The interval between each behavioral test
was 1–7 days. The mice were placed in a test room for 1 h before
starting the test. After each behavioral test, we returned the mice
to their individual cage. We recorded and analyzed the results
of some behavioral tests using the video-tracking ANY-maze
software (Stoelting Co., Wood dale, IL, USA).
Three-Chamber Sociability and Social
Novelty Test (TCT)
The three-chamber test was carried out to evaluate mice
sociability and social recognition according to our previous
reports (41, 42). Social approach was assessed in a three-chamber
box (41 × 21 × 35 cm) under 10 LX LED lights using a test
procedure that consisted of three stages. In the first stage, the
test mice were placed in the box and left on their own for
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FIGURE 1 | Experimental design. All experiments (A–D) were performed independently. In each experiment, mice were randomly distributed into the following groups:
(1) a group fed a normal diet (ND); (2) a group fed a high-fat diet (HFD); and (3) a group fed a high-fat diet and also administrated oxytocin (HFD + OXT) (Experiment A:
n = 21, B: n = 10, C: n = 8, D: n = 15 mice per group).
10min so they would habituate to their new environment. In the
second stage, an unfamiliar male stimulus mouse that had never
contacted the test mice. was placed in a triangle mesh cup at one
corner of the box and the test mice were allowed to freely move
around the chambers and investigate the newcomer for 10min
(sociability test). In the third stage, a novel stimulus mouse was
located in another cup at the opposite corner, and again the test
mice were allowed to freely move around between the chambers
and investigate the two stimulus mice for another 10min (social
recognition; Figure 3A). All tests were recorded and the stimulus
mice investigation time, which was defined as the amount of time
that the test mice were located within 5 cm of each cup, was
analyzed using the ANY-maze software.
Object Recognition Test (ORT)
The three-stage object recognition test (ORT) was performed as
previously described (43), with slight modifications. Briefly, in
the first stage, mice were placed into a square open field box (40
× 40× 40 cm) under 47 LX LED lights for 10min and allowed to
explore freely prior to being returned to their home cages. After
24 h, in the second stage, two identical objects were placed at two
different corners of the field box, and the mice were placed into
field and allowed to explore the two objects freely for 10min,
prior to returning to their home cage. After another 24 h, in the
third stage, the mice were returned to the field box and allowed
to explore one of the original objects together with a novel object
(Figure 3F). The exploration time with the familiar object and
the novel object was measured.
Object Location Test (OLT)
The object location test (OLT) was performed as previously
described (43), with slight modifications. Briefly, the three-stage
FIGURE 2 | Effect of high-fat diet to body. The body weight of each groups
before behavioral testing and OXT administration (n = 8 mice per group).
Results are displayed as mean ± SEM, ***p < 0.005.
procedure was performed in a square open field (40 × 40 ×
40 cm) with a black pattern picture on the wall under 47 LX LED
lights. In the first stage, mice were placed into the open field
box for 10min and allowed to explore freely and prior to being
returned to their home cage. After 24 h, in the second stage,
two identical objects were placed at two different corners of the
field. The mice were allowed to explore the two objects freely for
10min and then returned to their home cage. After another 24 h,
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FIGURE 3 | Effect of high-fat diet and oxytocin administration on social and object recognition memory. Schematic illustration of the three-chamber test: first stage
(habituation); second stage (social interaction) and third stage (social recognition) (A). (B–E) Time spent in each zone during 10 min: social interaction (D) and social
recognition (E) (n = 21 mice per group). Schematic illustration of object recognition test (F). Time to explore object in day 3 (n = 13 mice per group) (G). Schematic
illustration of object location test (H). Time to explore object in day 3 (I; n = 10 mice per group). Results are displayed as mean ± SEM, *p < 0.05, **p < 0.01,
***p < 0.005.
in the third stage, one of the objects was placed in a different
corner and the mice were allowed to freely explore the originally
and newly placed objects (Figure 3H). The exploration time with
each object was measured.
Olfactory Habituation/Dishabituation Test
The olfactory habituation/dishabituation test was carried out
as previously described (8, 44). The odorant stimuli used were
tap water, vanilla and lemon extracts (two non-social odorant
stimuli), and social odorants prepared by wiping cotton tips
across the bed of different male mice. The stimuli-soaked cotton
swabs were presented for 3min and then replaced with a
fresh swab scented with the same odorant for a total of three
presentations, with a 2 min-interval between them. We recorded
the cumulative time that mice spent sniffing the cotton swabs.
Open Field Test
The open field test was performed in a 50 × 50 × 40 cm opaque
gray chamber under 450 LX LED lights as previously described
(45). After a 10-min acclimation period in the test arena, the
mice were allowed to freely explore the field for 10min. Their
movements and other data were recorded and analyzed using the
ANY-maze software. The chamber was divided into 100 squares
by the software, with 16 squares covering the center zone of the
test arena, and the remaining 84 squares being regarded as the
corner zone. The total time spent and the duration of freezing in
each zone were analyzed.
Tail Suspension Test
The tail suspension test was performed to evaluate the
susceptibility to depression-like states, as previously described
(46). Each mouse was suspended 20 cm above the ground by the
tail for 6min using tape. The experiment was recorded using
a video camera, and the last 3min were used for analysis. The
amount of time that the mice spent being immobile was recorded
manually by an experimenter blinded to the mouse group.
Forced Swim Test
The forced swim test was performed to evaluate depressive-
like behavior, as previously described (47). Each mouse was
individually placed in an open, clear Plexiglas cylindrical
container (40 cm tall x 20 cm diameter) containing 20 cm of
water at 24◦C ± 1◦C for 6min. The first 3min were used for
habituation time and the last 3min for analysis. The experiment
was recorded by video camera. The immobility time was recorded
manually by an experimenter blinded to the mouse group.
Sacrifice and Tissue Harvesting
We sacrificed the mice 105min after OXT administration
(Figure 1, Experiment D). Brain tissue samples were collected
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FIGURE 4 | Effect of high-fat diet and oxytocin administration on anxiety behavior, fear-related behavior, and depressive-like behavior. Effect of a high-fat diet and
oxytocin administration on the time spent in the center area (A) and on freezing behavior (B) in the open field (n = 9–10 mice per group). Effect of a high-fat diet and
oxytocin administration on the immobility time in the tail suspension test (C) and forced swim test (D; n = 9–10 mice per group). Results are displayed as mean ±
SEM, *p < 0.05, **p < 0.01.
from the social recognition-related brain areas, including the
prefrontal cortex, lateral septum, medial amygdala, hippocampus
and the OXT-producing area of the brain (hypothalamus). Blood
samples were also collected. The samples were allowed to clot in
tubes and centrifuged at 4◦C for 10min at 3,000 rpm to separate
out the serum. The serum fraction and brain samples were stored
at−80◦C for further analysis.
RNA Isolation and Real-Time Polymerase
Chain Reaction (PCR)
Total RNA was isolated from brain tissues using a RNeasy
Lipid Tissue Mini Kit (Qiagen, Hilden, Germany) and reverse
transcription (RT) was performed using a PrimeScript RT
reagent Kit with gDNA Eraser (Takara, Kyoto, Japan). Real-
time quantitative PCR was then performed using the Thermal
Cycler Dice Real Time System III (Takara, Kyoto, Japan). For
each sample, a parallel reaction was set up with b-actin. Each
reaction was performed in duplicate. In real-time PCR analysis,









Mice were transcardially perfused with 10mM PBS, followed by
4% PFA in PBS 135min after OXT administration (Figure 1,
Experiment D). Brains were post-fixed in 4% PFA overnight at
4◦C and cyro-protected for 72 h in 30% sucrose at 4◦C before
freezing in OTC compound. Coronal sections at 30µm intervals
were processed using a cryostat (Leica Biosystems, Nussloch,
Germany). Sections were stored in PBS. Floating sections were
used to perform immunohistochemical labeling for detection of
OXT. Briefly, sections were washed in PBS for 10min, incubated
for 30min at room temperature in PBS containing 0.3% Triton
X-100, washed in PBS for 10min, incubated in PBS containing
5% MeOH, 0.2% Triton X-100 and 1.5% H2O2 for 60min in
order to inactivate endogenous peroxidase of sections. Sections
were washed in PBS for 10min, blocked in PBS containing
0.3% TritonX-100 and 10% normal horse serum for 30min at
room temperature.
Sections for immunocytochemical detection of OXT were
incubated with rabbit anti-OXT antibody (diluted 1:1000;
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FIGURE 5 | Effect of high-fat diet and oxytocin administration on sensory
functions. Sniffing time for each odor in the olfactory habituation/dishabituation
test (n = 8 mice per group). Results are displayed as mean ± SEM, *p < 0.05,
**p < 0.01, ***p < 0.005.
ImmunoStar, Hudson, WI, USA) at 4◦C for 24 h. Subsequently,
sections were washed three times in PBS and incubated with
peroxidase-labeled secondary antibodies (goat anti-rabbit IgG;
diluted 1:500; G-21234; Thermo Fisher Scientific, Waltham, MA,
USA) at 4◦C for 24 h. OXT immunoreactivity was visualized
as brown cytoplasmic precipitate with DAB (DAB Peroxidase
Substrate Kit; SK-4105; Vector Laboratories, Burlingame, CA,
USA). Sections were observed with a microscope (BZ-X700;
Keyence Co. Ltd., Osaka, Japan). The number of OXT positive
cells were counted manually by an experimenter blinded to the
mouse group, and taken as the average of the three slides from
each mouse.
Measurement of Serum OXT
We extracted OXT from blood serum using C-18 column
according to the manufacturer’s protocol. Extracted OXT levels
were measured using an enzyme-linked immunosorbent assay
(ELISA) kit (intra-assay coefficients of variation <13.3%, inter-
assay coefficients of variation <20.9%, Enzo Life Sciences, Inc.,
Farmingdale, NY, USA).
Statistical Analysis
All values are expressed as means ± standard error of the
mean (SEM). Data from the three-chamber, object recognition,
and object location tests were analyzed by Welch’s t-test.
Other experimental data on multi-group comparisons were first
analyzed by Levene’s test for variances. We performed one-way
ANOVA and post-hoc Tukey-Kramer tests as parametric analysis
or Kruskal-Wallis test and post-hoc Steel-Dwass test as non-
parametric analysis. P velue < 0.05 were considered statistically
significant. Statistical analyses of the experimental data were
performed with SPSS (IBM Corp., Armonk, NY, USA) and
R software.
RESULTS
Effect of OXT Administration on Social and
Object Recognition Memory in HFD-Fed
Mice
We analyzed recognition memory by using the three-chamber,
object recognition, and object location tests. Firstly, we
performed the three-chamber test to assess sociability and social
recognition (Figure 3A). In the first habituation stage, locomotor
activity of HFD and HFD + OXT mice was decreased compared
to ND mice [ANOVA: F(2,60) = 7.99, p = 0.001; Tukey’s test: ND
vs. HFD, p = 0.012; ND vs. HFD + OXT, p = 0.001; Figure 3B].
However, the ND, HFD, and HFD + OXT mice all stayed in
two zones for similar amounts of time (ND: p = 0.37; HFD: p
= 0.29; and HFD + OXT: p = 0.95; Figure 3C). In the second
stage, the ND, HFD, and OXT mice all spent more time with the
stimulus mice than with the empty cup (ND: p < 0.005; HFD: p
< 0.005; and HFD + OXT: p < 0.005; Figure 3D). In the third
stage, the ND mice spent more time with the novel mice than
the familiar ones, whereas the HFDmice spent a similar length of
time with the novel and familiar mice. The OXTmice spent more
time with the novel mice than the familiar one (ND: p = 0.042;
HFD: p = 0.79; and HFD + OXT: p = 0.048; Figure 3E). These
results indicate that the intake of a HFD impaired the ability of
mice in social recognition but not their sociability, and that OXT
administration ameliorated their impaired social recognition.
In the object recognition test (Figure 3F), the ND mice
investigated the novel object for a longer time than the familiar
object, whereas the HFDmice investigated the novel and familiar
objects for a similar amount of time. The OXT-administrated
mice investigated the novel object for longer than the familiar
one (ND: p = 0.016; HFD: p = 0.39; and HFD + OXT: p =
0.031; Figure 3G). These results indicated that a HFD intake
impaired object recognition memory in mice, and that OXT
administration ameliorated this.
In the object location test (Figure 3H), the ND mice
spent a longer time investigating the novel location of the
object than the familiar object location, whereas the HFD
mice spent a similar length of time investigating the objects
in the novel and familiar location. OXT-administrated mice
investigated the novel location object for a longer time
than the familiar location object (ND: p = 0.006; HFD: p
= 0.86; and HFD + OXT: p = 0.018; Figure 3I). These
results indicated that mice on a HFD had impaired object
location memory, and that OXT administration ameliorated
their this.
Anxiety- and Fear-Related Behavior in
HFD-Fed Mice, and the Effect of OXT
We analyzed anxiety- and fear-related behavior by using the
open field test. The time spent in the center area by the HFD
and the HFD + OXT mice was reduced compared to that of
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FIGURE 6 | Effect of high-fat diet and oxytocin administration on mRNA expression and serum OXT. Expression of c-fos, OXTR, and OXT mRNA was measured by
real-time PCR (n = 6–10 mice per group). c-fos mRNA expression in social recognition-related brain areas (prefrontal cortex, lateral septum, medial amygdala,
hypothalamus, and hippocampus) (A–E). OXTR mRNA expression in the above-mentioned brain regions (F–J). OXT mRNA expression in the hypothalamus (K).
Serum oxytocin (L). Results are displayed as mean ± SEM, *p < 0.05, ***p < 0.005.
FIGURE 7 | Effect of high-fat diet and oxytocin administration on OXT expression in the PVN. Expression of OXT protein in the PVN was measured by
immunohistochemistry. Photographs showing OXT immunoreactivity (brown cell body profiles) in the PVN (A:ND, B:HFD, C:HFD+OXT mice). Number of OXT
expressing cells after IP injection of OXT in PVN (n = 4–5 mice per group) (D). Scale bar: 100µm. Results are displayed as mean ± SEM, *p < 0.05.
the ND mice (ANOVA: F(2,26) = 5.45, p = 0.011; Tukey’s test:
ND vs. HFD, p = 0.039; ND vs. HFD + OXT, p = 0.014).
The HFD and the HFD + OXT mice spent similarly shorter
times in the center area (Tukey’s test: p = 0.931; Figure 4A).
The freezing time in the whole area was similar between the
ND and the HFD mice (Levene’s test: p = 0.024; Kruskal-
Wallis test: p = 0.009; and Steel-Dwass test: p = 0.84). In
contrast, the HFD + OXT mice showed more freezing time
compared to the ND and HFD mice (Steel-Dwass test: ND vs.
HFD + OXT, p = 0.0017; HFD vs. HFD + OXT, p = 0.038;
Figure 4B).
Effect of HFD and OXT Administration on
Depressive-Like Behavior
We analyzed depressive-like behavior by using the tail suspension
and forced swim tests. In the tail suspension test, immobility
time was similar among the ND, HFD, and HFD + OXT mice
(ANOVA: F(2,26) = 0.282, p = 0.757; Figure 4C). In contrast, in
the forced swim test, the immobility time of the OXTmice tended
to be shorter than that of theHFDmice (ANOVA: F(2,26) = 2.39, p
= 0.112; and Tukey test: p= 0.093). In contrast, the ND andHFD
mice showed similar immobility times (Tukey test: p = 0.511;
Figure 4D).
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Effect of HFD and OXT Administration on
Sensory Function
We performed the olfactory habituation/dishabituation test to
examine olfaction in HFD-fed mice by using the mouse’s
tendency to investigate a novel odor for a longer time. The
amount of time spent sniffing the first swab dipped into water
was similar among all three groups [ANOVA: F(2,21) = 1.29, p
= 0.296; Figure 5]. However, when lemon, vanilla, and social
odors were used, the first sniffing time of HFD mice decreased
compared to that of ND mice ([lemon, ANOVA: F(2,21) = 13.3,
p < 0.001; and Tukey test: p = 0.002], vanilla [ANOVA: F(2,21)
= 8.43, p = 0.002; and Tukey test: p = 0.006], and social odor
[ANOVA: F(2,21) = 8.16, p = 0.002; and Tukey test: p = 0.032]).
Furthermore, the sniffing time for these substances in the HFD+
OXTmice was almost equivalent to that in the HFDmice (Tukey
test: lemon, p = 0.682; vanilla, p = 0.979; and social odor p =
0.462). In HFD-fed mice, the impaired sensory function was not
ameliorated by peripheral OXT administration.
Effect of HFD and OXT Administration on
mRNA Expression of OXTR and c-fos
Genes
We analyzed brain OXTR and c-fos gene mRNA expression in
the social recognition-related nuclei including the prefrontal
cortex, lateral septum, medial amygdala, hypothalamus, and
hippocampus. In the prefrontal cortex [ANOVA: F(2,20) = 1.49,
p = 0.24], lateral septum [ANOVA: F(2,19) = 1.14, p = 0.893]
and medial amygdala [ANOVA: F(2,19) = 3.17, p = 0.732],
a HFD and the subsequent and peripheral administration of
OXT did not influence the expression of OXTR (Figures 6A–C).
In the hypothalamus, OXTR mRNA expression in the OXT-
administrated mice was decreased compared to the HFD mice
(ANOVA: F(2,21) = 5.45, p = 0.12; and Tukey test: p = 0.01;
Figure 6D). In the hippocampus, OXTR mRNA expression in
the HFD mice and OXT-administrated mice was decreased
compared to the ND mice [ANOVA: F(2,24) = 6.40, p = 0.006;
and Tukey test: p = 0.015, p = 0.011; Figure 6E]. In contrast,
intake of HFD and peripheral OXT administration did not affect
c-fos gene expression in the prefrontal cortex (ANOVA: F(2,20)
= 1.83, p = 0.18), lateral septum (ANOVA: F(2,24) = 1.98, p =
0.159), medial amygdala [ANOVA: F(2,22) = 5.57, p= 0.557] and
hypothalamus [ANOVA: F(2,20) = 0.66, p= 0.936; Figures 6F–I].
In the hippocampus, c-fos mRNA expression in the HFD and
OXT-administrated mice was decreased compared to the ND
mice [ANOVA: F(2,23) = 7.62, p = 0.003; and Tukey test: p =
0.017, p= 0.003; Figure 6J].
Effect of HFD and OXT Administration on
mRNA Expression of OXT Gene
We analyzed mRNA expression from the OXT gene in the
hypothalamus, which is the area of the brain that predominantly
synthesizes OXT. In the hypothalamus, the HFD did not
influence OXT gene expression. In contrast, in the OXT-
administrated mice, OXT gene expression was increased,
compared to that in the HFD mice [ANOVA: F(2,24) = 3.87,
p = 0.035; and Tukey test: p = 0.049; Figure 6K]. Peripheral
OXT administration also increased OXT gene expression in
HFD-fed mice.
Effect of HFD and OXT Administration on
Serum OXT and Body Weight
The body weight of HFD-fed mice (HFD, HFD+OXT mice)
was increased compared to normal diet fed mice (Kruskal-Wallis
test: p < 0.001; and Steel-Dwass test p < 0.001, p < 0.001).
We analyzed serum OXT after administration of OXT or saline.
In the OXT-administrated mice, the level of serum OXT was
increased compared to that of the ND and HFD mice (Kruskal-
Wallis test: p < 0.01; and Steel-Dwass test p < 0.001, p < 0.001;
Figure 6L).
Effect of HFD and OXT Administration on
OXT Expression in the PVN
We analyzed OXT expression in the PVN by
immunohistochemistry method (Figures 7A:ND, 7B:HFD,
7C:HFD+OXT mice). In the OXT-administrated mice, the
number of OXT expressing cells in the PVN was increased
compared to that in the HFD-fed mice (Kruskal-Wallis test: p <
0.05; and Steel-Dwass test p < 0.05) (Figure 7D).
DISCUSSION
Obesity induced by a HFD is recognized as one of the major
risk factors for lifestyle-related diseases, but it may also affect
psychopathology in patients and lead to abnormal behaviors
in their social life. In particular, obesity is associated with
Alzheimer’s disease (1, 2), cognitive decline (3), depression-
like behaviors (4), and anxiety behaviors (5). Therefore, a
comprehensive treatment approach is required to correct the
behavioral abnormalities caused by obesity.
OXT is known to improve social recognition. On the other
hand, OXT has also been reported to suppress food intake (48)
and fat accumulation (49). However, to date, the effect of OXT
administration on behavioral abnormalities induced by a HFD,
including overall cognitive functions such as social cognition,
object cognition, anxiety behavior, fear-related behavior, and
depression-like behavior remain inconclusive.
In this study, we demonstrate that the peripheral
administration of OXT in HFD-fed mice ameliorates the
decline in social recognition, object recognition and object
location memory. On the other hand, we found that anxiety-
related behavior was increased by peripheral OXT administration
in HFD-fed mice.
OXT can have controversial effects, depending on the dose
and administration route. For example, OXT had anxiogenic
effects when dosed at 10 ng/h for 15 days via i.c.v. administration
(34) and anxiolytic effects when dosed at 10 mg/kg via
intraperitoneal (i.p.) administration (50). The purpose of this
study was to examine the effect of OXT on behavior in relation
to social and non-social cognitive impairment in HFD-fed mice.
The administration dose (1 mg/kg, i.p.) was based on that used in
a previous study (6).
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Intake of a HFD decreased locomotor activity. However, in
the first stage of the three chamber test, the search time for the
two corners was similar between the groups, suggesting that a
decrease in search activity does not affect object identification.
In the first stage of the three chamber test, there was no
change in the search activity after the administration of OXT,
suggesting that OXT restored cognitive function independently
of the activity level.
With regards to recognition memory, OXT has a consistent
effect with different administration routes. Intranasal
administration of OXT ameliorated social recognition but
not object recognition in a valproic acid (VPA)-treated ASD
model in mice (28). Intraventricular OXT administration
ameliorated social recognition in shank3 KO mice. Moreover,
nasal OXT administration improves object recognition memory
in stressed rats (30).
Behavioral abnormalities similar to previous studies were
observed in HFD-fed mice, including object recognition, object
location memory, anxiety behavior, and depressive behavior. In
addition, we found that social recognition was decreased in HFD-
fed mice. A few reports exist on the social cognitive function
of HFD-fed mice. One study investigating mice on a HFD
demonstrated a decrease in social recognition memory (8), while
another study reported that their social memory did not decrease
(51). These contradictory results may be due to differences in the
protocol design for the behavioral testing. In the present study,
we confirmed a reduction in social memory in HFD-fed mice,
consistent with previously reported findings (8).
Social communication is a fundamental ability of social
animals, whereas impairment of communication ability is
observed as a core symptom in ASD patients and is an important
diagnostic criterion. Also, impairment of social memory is
observed as a common feature in ASD animal models such as
OXTR KO mice, Shank3 KO mice, and mice that receive fetal
VPA administration; these models are widely used to explore the
mechanisms underlying the development of ASD in the search
for new therapeutic strategies.
On the other hand, there are few animal models in which
social memory deteriorates due to environmental factors after
birth. The HFD-fed mice model showed a decline in social
memory due to environmental factors after birth, therefore
it could reflect some aspects of the symptoms of ASD in a
way different to other animal models of ASD. However, the
detailed mechanisms are still unclear and further studies are
required. It is expected that HFD-fed mice could be used to study
the mechanisms underlying psychiatric diseases accompanied
by social cognitive dysfunction such as dementia, or impaired
social memory such as ASD. Moreover, HFD-fed mice have the
potential to be utilized as a new psychiatric disease animal model
for the development of new medicines to treat or even cure
these disorders.
Some studies have reported a potential or direct relationship
between of the OXT/OXTR signaling system and social
recognition, object recognition, object location memory, anxiety
behavior, fear-related behavior, and depressive behavior (13, 35,
52, 53). We hypothesized that the OXT / OXTR system is
involved in the mechanisms leading to behavioral abnormalities
in HFD-fed mice. Therefore, we evaluated the mRNA expression
of OXT, OXTR, and c-fos in the brain of mice fed with
a HFD. The mRNA levels of OXTR and c-fos genes were
decreased in the hippocampus of HFD-fed mice. As we carried
out this experiment by injection of OXT or saline solution
intraperitoneally, the level of resultant c-fos expression may be
partially due to an effect caused by handling of the mice and
administration of these solutions.
Previous studies have reported that the hippocampus has a
critical role in social and emotional behaviors, such as social
recognition (22, 54), anxiety behavior, fear-related behavior
(55), and depressive behavior (56). OXTR-expressing neurons
in the hippocampus were also reported to play an essential
role in social memory (20). These reports suggested a close
relationship between the OXT/OXTR signaling system and
impaired behaviors in HFD-fed mice.
Serum OXT levels have been shown to decrease in HFD mice
(57). One possible explanation for the impairment in multiple
types of behavior among HFD-fed mice could be a reduction in
OXT/OXTR signaling. Based on this hypothesis, we attempted to
cure impaired behaviors in HFD-fed mice through the peripheral
administration of OXT.We found that peripheral administration
of OXT could ameliorate some of the impaired behaviors in
HFD-fed mice. Also, peripherally administrated OXT has been
reported to activate OXT neurons in the PVN via the peripheral
vagus nerve (58) and lead to increased release of internal OXT,
which is synthesized in the PVN (59). On the other hand, it has
been reported that peripherally administrated OXT can reach the
brain in rhesus macaque monkeys (60). It has been reported that
intake of a HFD causes blood-brain barrier (BBB) dysfunction
and increases BBB permeability (61). We could not exclude the
possibility that OXT permeability and brain translocation are
both increased in mice fed on a HFD.
In our study, peripheral OXT administration in HFD-fed
mice restored social cognitive function, object cognitive function,
object location memory, and depression-like behavior. A similar
effect has been observed on impaired social recognition in
HFD-fed rats (7). Thus, we suspected that may be a common
mechanism inducing social memory in mammals on a HFD. In
a similar experiment involving the intranasal administration of
OXT in a mouse model of ASD, where the ASD was induced
by exposure to valproic acid in utero, restoration of cognitive
function arose in a different manner, showing that the underlying
mechanisms depend on the animal model as well as the route of
OXT administration (28).
Object recognition is not affected by the administration of
i.c.v. OXTR antagonists to male mice, OXT knockout mice
showed no change in spatial memory performance (19), and
hippocampal OXTR was not necessary for object recognition
(20). As a result, the OXT / OXTR system in the brain is thought
to play a minor role in non-social recognition (15).
On the other hand, chronic i.c.v. administration of OXT
slightly improves object recognition in male rats for 7 days
(62), and nasal OXT improves cognitive function in stressed
rats (30). It is possible that the administration of OXT
by multiple administration routes could contribute to an
improvement in object recognition. However, since nasal OXT
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administration did not improve object recognition in VPA-
treated mice (28), further studies are needed on animal models
and routes of administration to evaluate the effects of OXT on
cognitive function.
With regard to social recognition, OXTR KO mice have
impaired social cognitive function, and hippocampal OXTRs
(20) are essential for social cognitive function. Therefore, it
can be said that the OXT/OXTR system is essential for social
cognitive functions.
Improvement of social cognitive function through
OXT administration has been confirmed in male rats by
intraventricular administration (63), intranasal administration
(28), and intraperitoneal administration (7). Therefore, it
was considered that the administration of OXT by multiple
administration routes may contribute to improved social
cognitive function.
The hippocampus is one of the brain areas that regulate
cognitive functions. Previous studies have suggested that the
OXT/OXTR system is involved in hippocampal neurogenesis
(64) and the subsequent formation of hippocampal-dependent
learning and memory (65). Thus, one possible mechanism
underlying the restoration of cognitive functions in HFD-fed
mice following administration of OXT may involve neurons
expressing OXTR in the hippocampus. In the near future,
we would thus like to confirm the effects of peripherally
administrated OXT on the activation of hippocampal neurons
expressing OXTR in OXTR-EYFP (OXTR-Venus) knock-in
mice fed on a HFD, in which OXTR neurons express Venus
protein (33).
The peripheral administration of OXT to HFD-fed mice did
not affect the duration of time spent in the center in our open
field tests. Previous studies however reported that wild-type
rats fed with normal chaw showed reduced anxiety behavior
when subjected to the open field test following the peripheral
administration of OXT (66). In our study, anxiety behavior was
not reduced in mice, suggesting that the pathology induced by
a HFD and the physiological effects of OXT administration may
not always be the same in rats and mice.
Freezing time is one of the indices used to indicate the level
of fear. In the present study, we showed that freezing time
was increased when OXT was administrated to HFD-fed mice.
This finding supports the notion that OXT may exert opposite
functions in enhancing or reducing anxiety and fear in male
rats and male humans, depending on the context, as found
in previous studies (35, 67). The effect of OXT on anxiety-
related behavior in this study was not observed in the center
time of the open field test, and only freezing behavior induced
anxiety. In the four plate test, the i.p. administration of 3 mg/kg
OXT had no effect, but 10 mg/kg OXT had an anxiolytic effect
(50). It is thought that the type of behavioral test and dose of
oxytocin could alter the effects of oxytocin on anxiety-related
behavior. Further studies are necessary to examine the dose and
administration route of OXT and their effects on fear behavior in
HFD-fed mice.
Previous studies using the tail suspension and forced swim
tests to evaluate the depression-like behavior of HFD-fed
mice yielded inconsistent results, with some studies describing
an increase in depression-like behavior (68), while others
did not show an increase (8). The index of depression-like
behavior might differ depending on experimental factors like the
behavioral test battery and environment. In the forced swim test,
we detected a tendency of OXT to have an anti-depressant effect
when administrated to HFD-fed mice. This result is consistent
with an antidepressant effect of OXT (31).
Next, we evaluated olfactory function, on the basis of the
ability of mice to identify individual mice which they had
encountered before (69). In a previous study (8), mice fed a HFD
showed a decrease in olfaction for physical odors, but in the
present study, we found that olfaction for social odors in HFD-
fed mice was also decreased. On the other hand, peripherally
administrated OXT did not restore impaired olfaction for both
physical and social odors in HFD-fed mice. These results imply
that OXT might restore the impaired social memory of HFD-fed
mice by a mechanism other than olfactory function.
As revealed by anatomical analyses, peripherally
administrated OXT reduced the expression of OXTR mRNA in
the hypothalamus of HFD-fed mice. A previous study reported
that chronic lateral ventricular infusion of OXT at 10 ng/h for
15 days decreased mRNA expression of OXTR in dorsolateral
septum (DLS), ventrolateral septum (VLS), basolateral amygdala,
medial amygdala, nucleus of the amygdala (CeA), and median
raphe nucleus and increased anxiety behavior (34).
Chronic third ventricular infusions of OXT caused down-
regulation of Arc and VMH OXTRs in rats (70). Repeated
administration of OXT to the lateral ventricle decreased OXTR
binding in the VMH, anterior olfactory nucleus (AOP), BNST,
CeA and the ventral septum (VS) (71). Repeated administration
of OXT (1,000 ng) did not change OXTR binding in AOP,
BNST, amygdala, VMH, and vs. after 24 h. However, there
was a slight decrease in OXTR binding in the AOP 72 h after
administration (71).
These studies suggest the existence of a negative feedback
mechanism in the OXT/OXTR system, and our results appear
to support this. However, it was reported that OXT treatment
reduced OXTR expression in the amygdala (71), but in this
study, OXTR expression was not reduced in the amygdala. We
could not exclude the possibility that the intake of a high-
fat diet may have some effect on the amygdala, but this is
currently unknown. Further studies on the downregulation of
OXTR in the amygdala are required. In addition, it has been
shown that OXT/OXTR has cell-specific effects in brain regions.
OXTR neurons in the cerebral cortex are glutamate receptor
neurons that control social cognition (72). In the hippocampus,
OXT promotes cortical information transfer and simultaneously
decreases background activity, significantly improving the signal-
to-noise ratio (73). Therefore, cell-type specific study using HFD-
fed mice would provide more informative insights regarding
cognitive impairment.
On the other hand, administration of OXT to HFD-fed mice
increased the expression of OXT mRNA in the hypothalamus.
Moreover, in the PVN, OXT-positive cells were increased. The
expression of OXT increased in the PVN. These results are
consistent with the finding that central OXT administration
induces hypothalamic OXT synthesis and release into the
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bloodstream (74). The relationship between reduced expression
of OXT/OXTR signal-related molecules in the hypothalamus and
changes in fear-related behavior inHFD-fedmice warrant further
investigation into the complex effects of OXT/OXTR signaling on
emotional and social behaviors.
OXTRs are also expressed on neurons localized in the PVN
and SON, the main nuclei where OXT-expressing neurons
such as the magnocellular and parvocellular neurons are also
located, suggesting a positive feedback loop or activation of
nearby neurons (75). Our data suggest that the positive feedback
mechanism of the OXT/OXTR signaling system might display
physiological roles in the response of HFD-fed mice to externally
administrated OXT.
In a previous report, serum OXT was reduced in HFD-fed
mice (57). To contrast, in the present study theHFDdid not affect
the level of serum OXT. In our experiments, we suspect that the
duration of the HFD and the age of the mice might have affected
the results.
This study showed that the intraperitoneal administration of 1
mg/kg of OXT to HFD-fed mice improved social and non-social
cognitive functioning and increased freezing behavior. However,
the effects of dose-response and the route of administration on
these effects are unknown, and should be analyzed in future
studies. In particular, anxiety behavior should be evaluated
in a multifaceted manner utilizing multiple behavioral studies
and doses.
Our study of peripherally administrated OXT to HFD-
fed mice showed amelioration of non-social as well as social
recognition. These results indicate the potential benefit of OXT
and OXTR agonists (76, 77) in treating patients who are suffering
from mental disorders induced by a HFD. OXT and artificially
developed OXTR agonists have potential as a therapeutic agent
to improve the cognitive decline associated with HFD.
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